Partnership brings Biocoat’s hydrophilic lubricious coating technology to Adam Spence’s custom catheters and promises collaboration to improve patient experience
HORSHAM, Pa. (PRWEB) August 21, 2018
A new strategic partnership between Biocoat, Inc. and Adam Spence, a Spectrum Plastics Group Company, will streamline the process of producing catheters used in vital vascular procedures, such as angioplasty, bypass surgery, fluid drainage, and other essential treatments.
The partnership allows Adam Spence’s innovative reinforced catheter shafts to receive Biocoat’s industry-leading hydrophilic coatings. The two companies have also committed to sharing expertise on the development of new products to improve patient experiences.
“This partnership is an excellent example of Biocoat’s commitment to providing superior surface coatings for high-demand, critical surgical devices. It creates a seamless solution for delivering Hydak® hydrophilic coatings for Adam Spence’s braided and coiled catheters and delivery systems, while allowing us to collaborate on new technologies,” said Jim Moran, President and CEO, Biocoat. “Adam Spence is committed to providing best-in-class solutions and superior quality, which makes them an ideal partner, and we look forward to years of productive collaboration.”
Founded in 1960, Adam Spence is a pioneer in the contract design and manufacture of medical device components. Today, the company produces custom products for many of the world’s leading medical device manufacturers.
The new partnership between Biocoat and Adam Spence capitalizes on the geographic proximity of the two organizations. Adam Spence develops and manufactures braid- and coil-reinforced delivery systems in Wall, NJ. Biocoat will apply and test its low-friction HYDAK® topcoat on these products at its nearby Horsham, PA facility. The two companies will share expertise in coated delivery systems – from development through full commercialization.
“Biocoat has deep experience in the application of low-friction hydrophilic coatings for catheters used in the cardiovascular, neurovascular, peripheral vascular, and structural heart markets,” said Steve Maxson, Vice President, Marketing and Sales, Adam Spence, A Spectrum Plastics Group Company. “This collaborative partnership will benefit both companies and our clients as we continue to develop solutions that improve the experience and outcomes for patients.”
About Biocoat, Inc.
Biocoat, Inc. develops and licenses biomaterial coatings for medical devices that are custom engineered to meet specific clinical parameters. The company specializes in supplying lubricious hydrophilic coatings for medical devices to original equipment manufacturers and contract manufacturers. Biocoat is also able to provide coating services to aspiring medical device companies that require assistance with manufacturing. The company also sells diagnostic test kits in the reproductive market for use in male factor infertility. Visit https://www.biocoat.com or connect on Twitter (@biocoat1) and LinkedIn.
About Adam Spence
Adam Spence designs and manufactures highly engineered medical extrusions, braid-reinforced tubing and catheter sub-assemblies for many of the world’s leading medical device OEMs. Originally founded as Adam Spence Corporation in 1960, the Company was acquired by WL Gore in 2004 and sold to Vance Street Capital in 2017 before being acquired by Spectrum Plastics Group in 2018. The company was a pioneer in the contract design and manufacture of medical devices and has been providing extrusions to medical device industry for over 55 years. http://www.adamspence.com.
Adam Spence is exhibiting at Medtec China with Spectrum Plastics Group on September 26-28 in Shanghai, China at stand #H002 — presenting its next generation reinforced tubing solutions.
For additional information:
Peg Beavers / firstname.lastname@example.org / 215-734-0888, ext. 135